高级检索
当前位置: 首页 > 详情页

Dicer induced reactive oxygen species inhibit hepatocellular carcinoma through interacting with cytochrome c oxidase

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Dept Endocrine & Metab Dis, Hosp 4, Shijiazhuang, Hebei, Peoples R China [2]Hebei Med Univ, Dept Gastroenterol & Hepatol, Hosp 4, Shijiazhuang, Hebei, Peoples R China [3]Hebei Med Univ, Anim Ctr, Hosp 4, Shijiazhuang, Hebei, Peoples R China [4]Hebei Med Univ, Dept Immunol & Rheumatol, Hosp 4, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China
出处:
ISSN:

关键词: Hepatocellular carcinoma dicer reactive oxygen species H2O2

摘要:
Dicer is an RNaseIII in microRNA processing that modulates multiple biological processes including tumorigenesis. We have shown that Dicer could inhibit the growth of hepatocellular carcinoma (HCC) previously [Zhang L, Wang C, Liu S, Zhao Y, et al. Oncol Lett 2016;11:3961-3966]. Here, we evaluated the relationships between Dicer and reactive oxygen species (ROS) as well as their modulation for HCC. We found Dicer expression was positively associated with ROS generation in HCC tissue at borderline statistical levels (p = .065); functional analysis showed Dicer could both induce the ROS generation (p < .01) and reduce the activity of Cytochrome c Oxidase (COX) (p < .05) by comparing the Dicer transfected and control HCC cells. The COX inhibitor ADDA-5 hydrochloride could increase the ROS generation, whereas the ROS scavenger N-acetylcysteine (NAC) could decrease the COX activity. Further analysis also demonstrated that one kind of ROS, H2O2, could repress the proliferation and migration as well as increase the apoptosis of HCC cells. Our data indicated that Dicer could inhibit the HCC growth by promoting ROS generation; ROS and COX interacted with each other to modify this process.

语种:
WOS:
中科院分区:
出版当年[2022]版:
大类 | 4 区 工程技术
小类 | 4 区 生物工程与应用微生物
最新[2025]版:
大类 | 4 区 生物学
小类 | 4 区 生物工程与应用微生物
JCR分区:
出版当年[2022]版:
Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
最新[2023]版:
Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Dept Endocrine & Metab Dis, Hosp 4, Shijiazhuang, Hebei, Peoples R China
通讯作者:
通讯机构: [4]Hebei Med Univ, Dept Immunol & Rheumatol, Hosp 4, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China [*1]Department of Immunology and Rheumatology, the Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050011, Hebei, P. R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号